Ascletis Pharma, Inc. Financial Overview
Ascletis Pharma, Inc.'s market cap is currently HK$12.99B. The company's EPS TTM is HK$-0.10025173067; its P/E ratio is -45.61; Ascletis Pharma, Inc. is scheduled to report earnings on August 15, 2025, and the estimated EPS forecast is HK$-0.35. See an overview of income statement, balance sheet, and cash flow financials.
